Institutional members access full text with Ovid®

Share this article on:

Intravenous Magnesium Sulfate Reduces Rates of Mechanical Ventilation in Pediatric Asthma

Shedd, Glenn Clinton DNP, FNP-BC; Noe, Sarah M. BSN, RN

Section Editor(s): Howard, Patricia Kunz PhD, RN, CEN, CPEN, NE-BC, FAEN, FAAN; Column Editors; Shapiro, Susan E. PhD, RN, FAAN; Column Editors

Advanced Emergency Nursing Journal: January/March 2014 - Volume 36 - Issue 1 - p 3–8
doi: 10.1097/TME.0000000000000009
Research to Practice

In this column, we examine an original research article by S. Torres et al. (2012) on the subject of magnesium sulfate use in pediatric patients with acute asthma. These researchers found that patients treated with 25 mg/kg of intravenous magnesium sulfate in addition to the conventional treatment options for acute asthma were less likely to require mechanical ventilation than patients in the control group. We review and critique this article and use a case study to illustrate the clinical implications of this research. We also examine some of the research and guidelines pertaining to the use of magnesium sulfate in acute asthma.

Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.

Corresponding Author: Glenn Clinton Shedd, DNP, FNP-BC, Nell Hodgson Woodruff School of Nursing, Emory University, 520 Clifton Rd NE, Atlanta, GA 30322 (gshedd@emory.edu).

Disclosure: The authors report no conflicts of interest.

Copyright © Wolters Kluwer Health, Inc. All rights reserved.